Quarterly Revenue
$9.22 M
+$4.52 M+96.29%
September 30, 2024
Summary
- As of February 7, 2025, GLUE quarterly revenue is $9.22 million, with the most recent change of +$4.52 million (+96.29%) on September 30, 2024.
- Over the past year, GLUE quarterly revenue has increased by +$8.15 million (+766.17%).
- GLUE quarterly revenue is now at all-time high.
Performance
GLUE Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$14.97 M
+$9.22 M+160.03%
September 30, 2024
Summary
- As of February 7, 2025, GLUE TTM revenue is $14.97 million, with the most recent change of +$9.22 million (+160.03%) on September 30, 2024.
- Over the past year, GLUE TTM revenue has increased by +$13.91 million (+1307.42%).
- GLUE TTM revenue is now at all-time high.
Performance
GLUE TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
GLUE Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +766.2% | +1307.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
GLUE Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +766.2% | at high | +1307.4% | ||
| 5 y | 5-year | at high | +766.2% | at high | +1307.4% | ||
| alltime | all time | at high | +766.2% | at high | +1307.4% |
Monte Rosa Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.22 M(+96.3%) | $14.97 M(+160.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $4.70 M(+341.3%) | $5.76 M(+441.3%) |
| Mar 2024 | - | $1.06 M | $1.06 M |
FAQ
- What is Monte Rosa Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly revenue year-on-year change?
- What is Monte Rosa Therapeutics TTM revenue?
- What is the all time high TTM revenue for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics TTM revenue year-on-year change?
What is Monte Rosa Therapeutics quarterly revenue?
The current quarterly revenue of GLUE is $9.22 M
What is the all time high quarterly revenue for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly revenue is $9.22 M
What is Monte Rosa Therapeutics quarterly revenue year-on-year change?
Over the past year, GLUE quarterly revenue has changed by +$8.15 M (+766.17%)
What is Monte Rosa Therapeutics TTM revenue?
The current TTM revenue of GLUE is $14.97 M
What is the all time high TTM revenue for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high TTM revenue is $14.97 M
What is Monte Rosa Therapeutics TTM revenue year-on-year change?
Over the past year, GLUE TTM revenue has changed by +$13.91 M (+1307.42%)